Enhertu Beats Chemotherapy for HER2-Low and -Ultralow Metastatic Breast Cancer
Jun 17, 2024
Enhertu offers better survival than chemotherapy for pre-treated, metastatic, HER2-low or -ultralow breast cancer. Read more…